Zacks Investment Research on MSN
Cardinal Health (CAH) stock moves -1.71%: What you should know
Cardinal Health (CAH) ended the recent trading session at $207.70, demonstrating a -1.71% change from the preceding day's closing price. The stock's performance was ahead of the S&P 500's daily loss ...
Cardinal Health's modeled fair value has been nudged from US$249.27 to US$249.60, a small shift that still matters if you are ...
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm ...
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even higher." ...
Zacks Investment Research on MSN
Are GLP-1 drugs becoming a meaningful revenue driver for CAH stock?
Cardinal Health CAH is clearly benefiting from the rapid adoption of GLP-1 therapies, though the impact remains more ...
Investors in Cardinal Health, Inc. (Symbol: CAH) saw new options begin trading today, for the February 2026 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CAH ...
Brown Advisory, an investment management company, released its “Brown Advisory Mid-Cap Growth Strategy” fourth-quarter 2025 ...
Cardinal Health, a Zacks Rank #1 (Strong Buy), operates as a healthcare services and products company in the United States and internationally. The company is essentially a middleman in the medical ...
Cardinal Health’s model fair value has been fine tuned to US$249.27 from US$248.80, a very small adjustment that keeps the price target effectively in the same range. That modest move sits alongside ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results